The Indian Journal of Tuberculosis - LRS Institute of Tuberculosis ...
The Indian Journal of Tuberculosis - LRS Institute of Tuberculosis ...
The Indian Journal of Tuberculosis - LRS Institute of Tuberculosis ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
LASER THERAPY IN TUBERCULOSIS 137<br />
group and 61 were kept as control group. Male to<br />
female ratio was 1.71:1. Mean age <strong>of</strong> patient was 30.78<br />
(Table 1), mean duration <strong>of</strong> illness before receiving<br />
therapy was 3.19 yrs. (Table 2). <strong>The</strong> most common<br />
drug resistance was found to be <strong>of</strong> Isoniazid ,<br />
followed by Pyrazinamide, Streptomycin and<br />
Rifampicin. In our study least resistant was found<br />
to be <strong>of</strong> Quinolone group (Cipr<strong>of</strong>loxacin ) (Figure-1).<br />
No. <strong>of</strong> patients<br />
70<br />
60<br />
50<br />
40<br />
30<br />
20<br />
10<br />
64<br />
48<br />
8<br />
16<br />
34<br />
62<br />
47<br />
13<br />
H : INH<br />
S : Streptomycin<br />
Pa : PAS<br />
T : Thiacetazone<br />
E : Ethambutol<br />
Z : Pyrazinamide<br />
R : Rifampicin<br />
K : Kanamycin<br />
Et : Ethionamide<br />
C : Cipr<strong>of</strong>loxacin<br />
28<br />
6<br />
0<br />
H S Pa T E Z R K Et C<br />
Resistant to<br />
Fig: Pattern <strong>of</strong> drug resistance according to culture sensitivity report<br />
Table 1: Age wise distribution <strong>of</strong> cases<br />
among LLLT Group and Control<br />
Group<br />
Age LLT Group Control Group<br />
(in yrs.) No. % No. %<br />
15-25 20 32.78 21 34.42<br />
26-35 26 42.62 23 37.70<br />
36-45 11 18.03 11 18.03<br />
46-55 3 4.91 6 9.83<br />
56-65 1 1.63 0 0<br />
Total 61 100 61 100<br />
(z test, z=0.09; p> 0.10; Insignificant)<br />
Table 2: Duration <strong>of</strong> illness before receiving<br />
treatment among LLLT Group and<br />
Control Group<br />
Duration LLT Group Control Group<br />
(in months) No. % No. %<br />
12-24 29 47.54 37 60.65<br />
25-36 15 24.59 7 11.47<br />
37-48 3 4.91 6 9.83<br />
49-60 5 8.19 5 8.19<br />
> 5 yrs 9 14.75 6 9.83<br />
Total 61 100<br />
(z test, z=1.45; p> 0.05; Insignificant)<br />
61 100<br />
<strong>Indian</strong> <strong>Journal</strong> <strong>of</strong> <strong>Tuberculosis</strong>